Metastatic Pancreatic Cancer:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Metastatic Pancreatic Cancer Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Metastatic Pancreatic Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Metastatic Pancreatic Cancer 23
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Metastatic Pancreatic Cancer Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
F. Hoffmann-La Roche Ltd. 34
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 34
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Sanofi 38
Clinical Trial Overview of Sanofi 38
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Celgene Corporation 40
Clinical Trial Overview of Celgene Corporation 40
Astellas Pharma Inc. 41
Clinical Trial Overview of Astellas Pharma Inc. 41
AstraZeneca PLC 42
Clinical Trial Overview of AstraZeneca PLC 42
Aduro BioTech, Inc. 43
Clinical Trial Overview of Aduro BioTech, Inc. 43
Clinical Trial Overview of Top Institutes / Government 44
National Cancer Institute 44
Clinical Trial Overview of National Cancer Institute 44
Sidney Kimmel Comprehensive Cancer Center 49
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 49
Roswell Park Cancer Institute 50
Clinical Trial Overview of Roswell Park Cancer Institute 50
Dana-Farber Cancer Institute, Inc. 51
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 51
The University of Texas M. D. Anderson Cancer Center 52
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 52
University of California, San Francisco 53
Clinical Trial Overview of University of California, San Francisco 53
Georgetown University 54
Clinical Trial Overview of Georgetown University 54
Massachusetts General Hospital 55
Clinical Trial Overview of Massachusetts General Hospital 55
The University of Iowa 56
Clinical Trial Overview of The University of Iowa 56
H. Lee Moffitt Cancer Center & Research Institute 57
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 57
Five Key Clinical Profiles 58
Appendix 151
Abbreviations 151
Definitions 151
Research Methodology 152
Secondary Research 152
About GlobalData 152
Contact Us 152
Disclaimer 153
Source 153


【レポート販売概要】

■ タイトル:Metastatic Pancreatic Cancer:グローバル臨床試験レビューH2, 2013
■ 英文:Metastatic Pancreatic Cancer Global Clinical Trials Review, H2, 2013
■ 発行日:2013年11月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162934
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。